A new study from experts at the University of Exeter has found that a widely used test for prostate cancer may leave black men at increased risk of overdiagnosis.
CHMP recommends AbbVie’s migraine drug, GSK’s anemia treatment
The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended this week that the European Commission authorize two new treatments for migraine and chronic